
Wickfield Capital engages Loop Capital Markets as exclusive investment bank for upcoming Signpath Pharma Capital Raise
Signpath Pharma, a portfolio company of Wickfield Capital, engaged Loop Capital Markets to raise capital for Signpath’s pivotal Phase III clinical trials. SANDY, UT, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- Signpath Pharma, a portfolio …